INFORMATION FOR RESEARCHERS REQUESTING DATA FROM THE NHVPR

Similar documents
The Australian Immunisation Register. Presented by Tracie Hibbard and Lauren Patron

Medical gap arrangements - practitioner application

No Jab, No Pay New Immunisation Requirements for Family Assistance Payments

Significant events in immunisation policy and practice* in Australia

standards for vaccinators and guidelines for organisations offering immunisation services

HPV Immunisation Uptake Statistics for the Catch-up Programme

ASAR. Australian Sonographer Accreditation Registry. Form 1-2. Application guide for entry onto the register of Accredited Student Sonographers

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedures 6 - Reporting Accreditation Decisions

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

The HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health

Impact for Indigenous Women: The VIP-I study and the National HPV Vaccine Program

HPV Immunisation Statistics Scotland

Autism Advisor Program NSW

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification

HPV Immunisation Statistics Scotland

City of Kingston Leisure Centre Health and Fitness Terms and Conditions

Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000)

The Future of Cervical Screening. Jenny Ross

Immunisation Policy. Country Children s Early Learning Ph: M:

Autism Advisor Program NSW

Application form for an Annual Practising Certificate 2017/2018 Application form for updating Practising Status 2017/2018 (Annual Renewal)

AUSTRALIAN IMMUNISATION REGISTER - ENHANCEMENTS

Women s and Children s Health Network

Autism Advisor Program NSW

Local Enhanced Service Specification. MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly

RACGP Immunisation Position Paper

Human papillomavirus and vaccination for cervical cancer

UICC HPV and CERVICAL CANCER CURRICULUM. UICC HPV and Cervical Cancer Curriculum Chapter 5. Application of HPV vaccines Prof. Suzanne Garland MD

Criteria and Application for Men

NIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement

Camden Clinical Commissioning Group

Nursing and Midwifery students only. Section 1: Information

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

MICHIGAN OFFICE OF SERVICES TO THE AGING. Operating Standards For Service Programs

Aboriginal and Torres Strait Islander women and cervical cancer prevention. Menzies School of Health

BMA INFORMATION BULLETIN No. 23. International Safety Management (ISM) Code

1. NHS (GENERAL DENTAL SERVICES) (SCOTLAND) AMENDMENT REGULATIONS AMENDMENT NO 136 TO THE STATEMENT OF DENTAL REMUNERATION

New regulatory requirements DPCS Regulations 2017

Amendments to the Mental Health Act 1986 (Vic) regarding involuntary treatment and Community Treatment Orders

IMMUNISATION POLICY. Explanation: It is imperative that children are kept safe and healthy at all times in the centre environment.

Asthma Management Policy

Application form for an Annual Practising Certificate 2018/2019 Application form for updating Practising Status 2018/2019 (Annual Renewal)

NHS public health functions agreement Service specification No.12 Td/IPV (teenage booster) immunisation programme

MEDICAL ASSISTANCE BULLETIN

Data Flows for Direct Commissioning v1.54 Activity Reporting Programme Child Immunisations UNIFY Collections: Guidance

Primary Health Networks

IMPORTANT: CURRENT STUDENT MEDICAL & PARENT ADDRESS DETAILS

NHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

Immunization Report Public Health September 2013

PHN - Western Victoria Immunisation Forum Chelsea Taylor Senior Policy Advisor Immunisation, DHHS 21 October 2017

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedure 9 - Annual Reporting Requirements for Accredited Sonography Courses

National Drug and Alcohol Treatment Waiting Times Report

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

National Drug and Alcohol Treatment Waiting Times

2010 Sharing Hope Program for men

Recreational Calisthenics Policy

Policy for Authorisation of Independent Vaccinators

TARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.

The principles of the Higher Education and Research Reform Bill 2014, and related matters Submission 64

IMMUNISATION. Database & Forms Vaccination & Immunisation System. Margaret Fogarty ADPHN / Immunisation

2018 Immunisation Update

BACKGROUND TO THE INTRODUCTION OF THE HUMAN PAPILLOMAVIRUS TO JAMAICA

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians

Guideline on the Regulation of Therapeutic Products in New Zealand

The HPV vaccination programme in Flanders. Geert Top MD Infectious disease control and vaccination

California Comprehensive Addiction Recovery Act; Physical Capacity Expansion for Addiction Treatment

Certificate IV in Mental Health Peer Work CHC43515 Scholarships Application Form

National Drug and Alcohol Treatment Waiting Times

The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland

Local CQUIN Template School Aged Immunisation Programmes

Overview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care

ENROLMENT FORM. Title: First Name: Surname: Postal Address: Postcode: Emergency Contact: Relationship: Phone: What is your main fitness goal?

MEMORANDUM OF UNDERSTANDING THE INDEPENDENT FUNDRAISING STANDARDS & ADJUDICATION PANEL FOR SCOTLAND AND THE FUNDRAISING REGULATOR

Feidhmeannacht na Seirbhíse Sláinte

One of Diabetes Queensland key strategies to improve lives is through research.

3. Title Vaccination and immunisation data return collected through the COVER

The Australian Market & Social Research Society (AMSRS) Introduction AMSRS Guidelines and regulations General...

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for

IT and Information Acceptable Use Policy

Initial Clinical History and Physical Form

Current Immunisation Issues in the Nepean Blue Mountains Presented as part of the Immunisation Update education series in October 2017

Access Points: Frequently Asked Questions 15 June 2016

SUBJECT: HPV vaccination programme update

Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641

Home Sleep Test (HST) Instructions

Research Scholarships for PhD Students

Completed applications can be submitted either by mail or to:

Changes to cervical screening. Information for patients

Details of Authorised Personnel

Revitalising the National HPV Immunisation Programme. with agreed outcomes from the August 2014 workshop

IMPORTANT: STUDENT MEDICAL & PARENT ADDRESS DETAILS UPDATE

Quality of Life of HIV-infected Patients Study

Grant Application for Individuals

This Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...

The Introduction of Primary HPV Screening in Australia

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

Transcription:

INFORMATION FOR RESEARCHERS REQUESTING DATA FROM THE NHVPR What is the NHVPR? The National Human Papillomavirus Vaccination Program Register (NHVPR) is the Australian register which records HPV vaccine doses delivered as part of the National HPV Vaccination Program. The Program commenced in 2007 offering HPV vaccine to girls in the first year of high school (at age 12-13 years). A catch up program for females up to the age of 26 ran from 2007-2009. In 2013, the Program was expanded to include vaccinations for males in the first year of high school (at age 12-13 years). A catch up program for males aged 14-15 years ran in 2013 and 2014. Who can access NHVPR data? The NHVPR is owned by the Australian Government Department of Health (DOH) and operated by VCS Ltd. All requests for data from the NHVPR must be approved by the DOH. NHVPR purposes The purposes of the NHVPR, as defined by the National Health Amendment (National HPV Vaccination Program Register) Act 2007, are to ensure the successful implementation of the National Human Papillomavirus (HPV) Vaccination Program, and in doing so facilitate: i. establishment and maintenance of an electronic database of records for monitoring vaccination of participants in the HPV Program; ii. monitoring of the effectiveness of HPV vaccine in preventing certain cervical cancers by allowing for future cross referencing of data against Pap Smear and other cervical cytology or cervical cancer registers maintained by States and Territories; iii. establishment of mechanisms to advise eligible persons, or the parents or guardians of children, if doses of HPV vaccine have been missed or if booster doses are required in the future; iv. maintenance of a record of the HPV vaccination status of eligible persons for the purposes of certifying the completion of the course of vaccination; and, v. promotion of the health and wellbeing of persons by providing information on new developments associated with the Program to vaccination providers, eligible persons and parents or guardians of children. Thus the legislation does not state that a primary function of the register is to provide data for research purposes. However analysis and dissemination of registry data would be required to fulfil the functions of items (ii) monitoring of effectiveness and (v) promotion of health and wellbeing by producing information. The accompanying explanatory memorandum flags that De-identified statistical information may also be published to raise awareness in the general population. Information stored by the NHVPR The NHVPR records notifications of HPV vaccines received by eligible persons in Australia, primarily as part of the National HPV Vaccination Program (doses paid for privately outside of the program may also be reported to the Register). A complete vaccination course consists of three doses of HPV vaccine and the Register matches individual vaccination dose notifications received to individuals on the register to assess vaccination completion. Page 1 of 7

The target population for the National HPV Vaccination Program 2007-2009 was all females aged 12-26 years in this period i.e. DOB July 1980 to 1997 (the general practice/community based program for women aged up to 26 commenced July 2007.) The ongoing target population is females in the first year of high school (usually aged 12-13 years) and, from 2013, males in the first year of high school and 2013/2014 two catch up cohorts of boys in their second and third year of high school. For doses delivered in school based programs, notification of doses to the Register should be close to complete (data transfer from State/Territory administered school-based programs should be complete but some consumers may opt-off and not consent to transfer of their data to the NHVPR). For doses delivered in general practice and other community based settings, notification of doses may not be complete. Vaccine providers are required to seek patient consent to notify the register of their doses. GPs received an incentive notification payment of $6 per dose for doses administered on or before 31st December 2009 and notified before June 2010. Vaccine recipients may opt off the Register at any time. Register information is held in a database and includes the following collected information: - name; (mandatory field) - date of birth (mandatory field) - Sex (mandatory field from 2013) - address (mandatory field) - Medicare number (voluntary field) - parent/guardian s name(voluntary field) - parent/guardian s address(voluntary field) - school details (voluntary field) - practitioner and clinic details (mandatory field) - date of vaccination (mandatory field) - type of vaccine (mandatory field) - dose number (mandatory field) - batch number (voluntary field) - Indigenous status (voluntary field) The NHVPR also stores calculated fields which include (but are not limited to): - Implied dose number (the dose number implied by the vaccination date, with reference to other doses notified to the NHVPR) - Age at current date - Age at each implied dose - Total doses for each consumer - Consumer completion status (whether vaccination course complete) - Date of course completion - Whether the consumer was vaccinated as part of the schools/community program (defined as receiving any doses from a non-gp provider. Note that consumers vaccinated at non-gp providers but not in school settings (e.g. community clinics) are also designated as part of the schools/community program.) Please note that the NHVPR contains no other personal information such as marital status, country of birth, ethnicity, or socio-economic status of eligible persons vaccinated. It does not contain results of HPV DNA testing, Pap test results or information about adverse events following immunisation. Doses of both the quadrivalent vaccine Gardasil and bivalent vaccine Cervarix are recorded on the NHVPR. Information published by the NHVPR National coverage data is available on the NHVPR website at: http://www.hpvregister.org.au/research/coverage-data Page 2 of 7

Details of published research can be found at: http://www.hpvregister.org.au/research/relevant-research-publications A number of standard statistical reports containing aggregated data are released on a quarterly basis to state and territory health authorities using on-line facilities and to the Australian Government Department of Health. These are available to authorised users only at this stage. Information that can be provided by the Register on request and with DOH approval A Data Request form can be submitted by researchers to the NHVPR after the request has been discussed with a Registry Health Information Manager. Where the research proposal is particularly complex, the Health Information Manager may seek the input of the VCS Registries Research Review team (data managers, medical director/epidemiologists) to enable appropriate feedback to the researcher prior to submitting the request to DOH. Data provided by the NHVPR is to be used only for the explicit purpose for which it was requested and is not to be published in a format that could potentially identify an individual. Data requests fall into two types: 1. Summary or aggregate data 2. line/itemised data 1. Summary or aggregate data request Upon request, aggregate or group summary data can be provided once approved by DOH (see section A of request form). No individual data are provided as the data are summarised. If the request for aggregate numbers is at a level small enough that an individual could possibly be identified (such as with age groups within a remote location) then a summary of the data may only be provided, or censoring of some cells may occur (for example cells with fewer than 10 people). Examples of aggregate data requests would include: - total number of HPV doses by State and year of administration - vaccination coverage rate by age, State and dose number, using ABS estimated residential populations as the denominator - Number of consumers completing vaccination course within 6 months and one year. - Number of consumers vaccinated in general practice by age. 2. Line/ itemised data request Individual line data may be provided by the NHVPR subject to the researchers providing documentation of ethical approval for such release from a properly constituted Human Research Ethics Committee, and following review and approval by the DOH. The Register refers to statements on individually identifiable, reidentifiable and non-identifiable data made in the NHMRC National Statement on Ethical Conduct in Human Research (2007) (updated may 2015) as specified below: Individually identifiable data, where the identity of a specific individual can reasonably be ascertained. Examples of identifiers include the individual s name, image, and date of birth or address; Re-identifiable data, from which identifiers have been removed and replaced by a code, but it remains possible to re-identify a specific individual by, for example, using the code or linking different data sets Page 3 of 7

Non-identifiable data, which have never been labeled with individual identifiers or from which identifiers have been permanently removed, and by means of which no specific individual can be identified. A subset of non-identifiable data are those that can be linked with other data so it can be known that they are about the same data subject, although the person s identity remains unknown. The NHVPR will review whether the data sought will be individually identifiable, potentially re-identifiable or non-identifiable. Where third parties hold individual consent from the consumer to release information held on the NHVPR to them, individually identifiable data can be lawfully released from the NHVPR. Consent forms must be provided to the Register in order for the data to be released. As a Commonwealth owned data collection, release of personal information from the NHVPR for use in research or statistical purposes without individual consent is governed by the Australian Privacy Principles in Schedule 1 of the Privacy Act 1988. Specifically APP6 (Use or disclosure of personal information) provides guidance upon specific circumstances when such release is lawful. Guidelines under Section 95 of the Privacy Act 1988 provide explicit guidance for researchers as to the requirements for seeking and obtaining approval from a Human Research Ethics Committee for release of identified or re-identifiable information. The researchers must clearly show how the public interest in the research outweighs the public interest in adhering to the relevant information privacy principle(s). Decisions regarding release of line data from the NHVPR will be made by the owners of the NHVPR, the DOH. They will require the full research proposal, and copies of any ethics submissions and approvals which clearly identify the potential ethical and privacy concerns to inform their decision. These documents should be provided to the NHVPR at the time of submission of the data request form. The NHVPR will forward the request to DOH. Human Research Ethics Committee (HREC) approval It is strongly recommended that HREC approval is obtained for all line data requests. The NHVPR and DOH reserve the right to request that HREC approval is obtained, including for requests for aggregated data. Whilst a HREC will determine the ethical acceptability of such proposals, the authority to release data lies with the DOH. Limitations to data that can be provided by the NHVPR Data about HPV vaccination coverage in the National HPV Vaccination program can be provided but when interpreting these estimates it is important that researchers be aware that measurement error may affect both the denominator and the numerator. The denominator for coverage estimates is Australian persons eligible for vaccination under the Program: the best available estimates of this population are from ABS ERPs. For small areas and Indigenous populations these estimates are less robust. The numerator comprises HPV vaccination doses notified to the NHVPR. For doses administered in school based programs, central notification processes should mean that doses notified closely equate to doses administered (i.e. with the exception of doses delivered to consumers who did not consent for their data to be transferred to the NHVPR.) Consent forms and policies differ slightly across States and Territories. Doses delivered in other settings may be incompletely notified as notification is not compulsory and requires consent Page 4 of 7

from the vaccinated person. The extent of notification may also differ by State/Territory. The Northern Territory and Queensland have state based vaccination registers and centrally notify HPV vaccine doses administered from all providers, and are therefore likely to have the most complete data. South Australia also collected HPV vaccination dose information from providers during the first year of the catch-up program and notified it centrally. It should also be noted that the NHVPR Coverage data currently does not include doses administered outside of the recommended minimum intervals (too close to previous dose) as valid doses. These doses (dose 2 or dose 3) are excluded from coverage calculations. The NHVPR uses record-linkage methods to match doses received from different vaccination providers to the same individual (e.g. dose 1 received at school, dose 2 at surgery 1 and dose 3 at surgery 2). Imperfect recordlinkage between vaccine doses from the same person could result in an overestimate of the number of people receiving any vaccine doses and an underestimate of the percentage of courses completed. For these reasons data provided by the NHVPR is intended to be used as a guide only and should be interpreted with caution. Process to request data from the NHVPR The steps to request data are summarised below: 1. To determine the precise data needs, the request should first be discussed with a NHVPR Health Information Manager on 1800 478 734. 2. Initial discussions with the Health Information Manager will assist in clarifying what is required and the feasibility of the request. It is helpful for the request to be specific by stating which variables are required, the time frame, the location and the population. Providing a mock-up table of how the data is to be presented is very useful. 3. The researcher must then submit a Request Form for data from the NHVPR. Ensure that any necessary attachments are also provided. Applications can be submitted by fax (03) 8417 6835 or by email to datarequests@vcs.org.au. 4. The application will be forwarded by the NHVPR to the DOH, owners of the NHVPR, for approval to release the data. The researcher will then be notified of the outcome and, if approved, given a timeline for the release of the data request. Data format Data files will typically be in Microsoft Excel format, PDF or CSV and password protected as required. Conditions of use of data 1. Third parties who are provided with any data from the NHVPR are required to comply with all relevant legislation and guidelines including: The 13 Australian Privacy Principles (Commonwealth Privacy Act). Particularly: - the collection and use of information is necessary for research relevant to public health or public safety or the compilation or analysis of statistics relevant to public health or public safety(privacy Act Section 16B) - information does not identify any individual or from which the individual s identity cannot reasonably be ascertained - health information is not disclosed to another party or published in a form where an individual can be identified (Privacy Act Section 16B) Page 5 of 7

- reasonable steps are taken to protect the health information from misuse, interference and loss, and to protect information from unauthorised access, modification or disclosure (APP 11.1) - take reasonable steps to destroy or de-identify health information if it is no longer needed (APP 11.2) - Information to be transferred out of Australia must abide by APP 8. - Guidelines Approved under Section 95A of the Privacy Act, including written proposals to a HREC to use health information. 2. Third parties are only to use data from the NHVPR for the purpose specified on the Request for Data Form. 3. Third parties must not publish NHVPR data without first informing the NHVPR. 4. Third parties must provide a copy of all released reports or published manuscripts to the NHVPR for our records. 5. Third parties must comply with any other requirements specified by DOH as a condition of approving data release. 6. The NHVPR must be acknowledged in all publications and reports where NHVPR data has been used and the acknowledgement include the statement that The NHVPR is fully funded by the Australian Government and operated by the Victorian Cytology Service Ltd. 7. Third parties must ensure that any data, whether identified or de-identified, are stored securely and only those named in the application form will have access to it. 8. Data from the NHVPR is not to be published in a format that could potentially identify an individual consumer (for example cells with fewer than 10 people). 9. Third parties must agree to provide an annual update or more frequently if requested, to the NHVPR regarding the status of the research/use of data and certify ongoing safe storage of the data. 10. Third parties must agree to pay a cost recovery fee in order to obtain the data requested if applicable. 11. Notify the NHVPR of any changes of staff who hold the NHVPR data. 12. Not link NHVPR data to another dataset without appropriate approval. The NHVPR is fully funded by the Australian Government and operated by VCS Ltd. Useful references National HPV Vaccination Program Register website www.hpvregister.org.au Australian Immunisation Handbook http://www.health.gov.au/internet/immunise/publishing.nsf/content/handbook10-home HPV Vaccination Program information on the Immunise Australia website http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/content/immunise-hpv NH&MRC Guidelines Approved under Section 95A of the Privacy Act 1988 http://www.nhmrc.gov.au/guidelines-publications/pr2 NH&MRC Guidelines under Section 95 of the Privacy Act 1988 http://www.nhmrc.gov.au/guidelines-publications/pr1 Page 6 of 7

National Statement On Ethical Conduct In Human Research (NHMRC, 2007 updated May 2015) http://www.nhmrc.gov.au/guidelines-publications/e72 Privacy Act 1988 http://www.comlaw.gov.au/series/c2004a03712 Page 7 of 7